EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation between Long-term Glycemic Control (HbA1c) and Serum Glial Fibrillary Acidic Protein (GFAP) as a Biomarker for Neuroinflammation in Diabetic Patients

Hassanein Fadel Mohammed

Medical Science Journal for Advance Research · 01.06.2026 · 7 (2)

DOI: 10.46966/msjar.v7i2.397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 01.06.2026. Verfasst von Hassanein Fadel Mohammed. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroinflammation is a big contributor to Type 2 Diabetes. This study examined the connection between the two markers of chronic glycemic control, HbA1c, and Glial Fibrillary Acidic Protein (GFAP), which measures astrocyte injury. We speculate that sustained hyperglycaemia induces blood brain barrier disruption and astrogliosis that results in an increase of systemic GFAP. Method:The number of subjects enrolled were 150 (Controls, Controlled DM, and Uncontrolled DM). The HbA1c was determined by HPLC and the serum GFAP level was quantified by high-sensitivity ELISA kits. For statistical analyses, ANOVA and Pearson's correlation were used.

Results

The GFAP level was significantly higher (p

Zitieren

APA

Mohammed, H. F. (2026). Correlation between Long-term Glycemic Control (HbA1c) and Serum Glial Fibrillary Acidic Protein (GFAP) as a Biomarker for Neuroinflammation in Diabetic Patients. Medical Science Journal for Advance Research, 7(2). https://doi.org/10.46966/msjar.v7i2.397

Vancouver

Mohammed HF. Correlation between Long-term Glycemic Control (HbA1c) and Serum Glial Fibrillary Acidic Protein (GFAP) as a Biomarker for Neuroinflammation in Diabetic Patients. Medical Science Journal for Advance Research. 2026;7(2). doi:10.46966/msjar.v7i2.397

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Hassanein Fadel},
  title = {Correlation between Long-term Glycemic Control (HbA1c) and Serum Glial Fibrillary Acidic Protein (GFAP) as a Biomarker for Neuroinflammation in Diabetic Patients},
  journal = {Medical Science Journal for Advance Research},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.46966/msjar.v7i2.397}
}
Kostenlos starten →